Efficacy and Safety of BI 201335 (Faldaprevir) in Combination With Pegylated Interferon-alpha and Ribavirin in Treatment-naïve Genotype 1 Hepatitis C Infected Patients (STARTverso 2)
Clinical trial NCT01297270 · COMPLETED
Trial details
- NCT number
- NCT01297270
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-01
- Primary completion
- 2014-04-01
- Enrollment
- 658
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.